178 related articles for article (PubMed ID: 27362817)
21. CMV-specific Cell-mediated Immunity at 3-month Prophylaxis Withdrawal Discriminates D+/R+ Kidney Transplants at Risk of Late-onset CMV Infection Regardless the Type of Induction Therapy.
Jarque M; Melilli E; Crespo E; Manonelles A; Montero N; Torras J; Cruzado JM; Luque S; Gil-Vernet S; Grinyó JM; Bestard O
Transplantation; 2018 Nov; 102(11):e472-e480. PubMed ID: 30130330
[TBL] [Abstract][Full Text] [Related]
22. Incidence and risk factors for cytomegalovirus disease in a Colombian cohort of kidney transplant recipients.
Díaz J; Henao J; Rodelo J; García A; Arbeláez M; Jaimes F
Transplant Proc; 2014; 46(1):160-6. PubMed ID: 24507044
[TBL] [Abstract][Full Text] [Related]
23. [Correlation analysis of survival period and CD4+ Tcell-iATP levels in liver transplant recipients].
Qu W; Sun L; Zhu Z; Liu Y; Wei L; Zeng Z
Zhonghua Gan Zang Bing Za Zhi; 2014 Sep; 22(9):693-7. PubMed ID: 25369255
[TBL] [Abstract][Full Text] [Related]
24. Post-transplant monitoring of NK cell counts as a simple approach to predict the occurrence of opportunistic infection in liver transplant recipients.
Fernández-Ruiz M; Silva JT; López-Medrano F; Allende LM; San Juan R; Cambra F; Justo I; Paz-Artal E; Jiménez C; Aguado JM
Transpl Infect Dis; 2016 Aug; 18(4):552-65. PubMed ID: 27260953
[TBL] [Abstract][Full Text] [Related]
25. Herpes zoster in kidney transplant recipients: protective effect of anti-cytomegalovirus prophylaxis and natural killer cell count. A single-center cohort study.
Fernández-Ruiz M; Origüen J; Lora D; López-Medrano F; González E; Polanco N; San Juan R; Ruiz-Merlo T; Parra P; Andrés A; Aguado JM
Transpl Int; 2018 Feb; 31(2):187-197. PubMed ID: 28940695
[TBL] [Abstract][Full Text] [Related]
26. Correlation Between Survival Interval and CD4
Qu W; Zhu ZJ; Sun LY; Wei L; Liu Y; Zeng ZG
Transplant Proc; 2017 Mar; 49(2):316-321. PubMed ID: 28219591
[TBL] [Abstract][Full Text] [Related]
27. Kinetics of peripheral blood lymphocyte subpopulations predicts the occurrence of opportunistic infection after kidney transplantation.
Fernández-Ruiz M; López-Medrano F; Allende LM; Andrés A; García-Reyne A; Lumbreras C; San-Juan R; Morales JM; Paz-Artal E; Aguado JM
Transpl Int; 2014 Jul; 27(7):674-85. PubMed ID: 24650360
[TBL] [Abstract][Full Text] [Related]
28. Viral load, CMV-specific T-cell immune response and cytomegalovirus disease in solid organ transplant recipients at higher risk for cytomegalovirus infection during preemptive therapy.
Martín-Gandul C; Pérez-Romero P; Blanco-Lobo P; Benmarzouk-Hidalgo OJ; Sánchez M; Gentil MA; Bernal C; Sobrino JM; Rodríguez-Hernández MJ; Cordero E;
Transpl Int; 2014 Oct; 27(10):1060-8. PubMed ID: 24964364
[TBL] [Abstract][Full Text] [Related]
29. Increased risk of breakthrough infection among cytomegalovirus donor-positive/recipient-negative kidney transplant recipients receiving lower-dose valganciclovir prophylaxis.
Stevens DR; Sawinski D; Blumberg E; Galanakis N; Bloom RD; Trofe-Clark J
Transpl Infect Dis; 2015 Apr; 17(2):163-73. PubMed ID: 25661673
[TBL] [Abstract][Full Text] [Related]
30. Kinetic of the CMV-specific T-cell immune response and CMV infection in CMV-seropositive kidney transplant recipients receiving rabbit anti-thymocyte globulin induction therapy: A pilot study.
Martín-Gandul C; Pérez-Romero P; Mena-Romo D; Molina-Ortega A; González-Roncero FM; Suñer M; Bernal G; Cordero E;
Transpl Infect Dis; 2018 Jun; 20(3):e12883. PubMed ID: 29570917
[TBL] [Abstract][Full Text] [Related]
31. Development of a Predictive Model Using Endoscopic Features for Gastric Cytomegalovirus Infection in Renal Transplant Patients.
Yeo SJ; Kwon KT; Kim ES; Jung MK; Kim SK; Lee HS; Lee JS; Lee SW; Lee YJ; Kwak SG; Han S
Transplantation; 2019 May; 103(5):998-1004. PubMed ID: 30507742
[TBL] [Abstract][Full Text] [Related]
32. Monitoring peripheral blood CD4+ adenosine triphosphate activity in recurrent hepatitis C and its correlation to fibrosis progression.
Alkhouri N; Hanouneh IA; Lopez R; Zein NN
Liver Transpl; 2010 Feb; 16(2):155-62. PubMed ID: 20104483
[TBL] [Abstract][Full Text] [Related]
33. Cytomegalovirus infection after acute rejection therapy in seropositive kidney transplant recipients.
Lee YM; Kim YH; Han DJ; Park SK; Park JS; Sung H; Hong HL; Kim T; Kim SH; Choi SH; Kim YS; Woo JH; Lee SO
Transpl Infect Dis; 2014 Jun; 16(3):397-402. PubMed ID: 24810355
[TBL] [Abstract][Full Text] [Related]
34. A prospective longitudinal analysis of cytomegalovirus (CMV)-specific CD4+ and CD8+ T cells in kidney allograft recipients at risk of CMV infection.
Eid AJ; Brown RA; Arthurs SK; Lahr BD; Eckel-Passow JE; Larson TS; Razonable RR
Transpl Int; 2010 May; 23(5):506-13. PubMed ID: 19951371
[TBL] [Abstract][Full Text] [Related]
35. Monitoring of CMV-specific cell-mediated immunity with a commercial ELISA-based interferon-γ release assay in kidney transplant recipients treated with antithymocyte globulin.
Fernández-Ruiz M; Rodríguez-Goncer I; Parra P; Ruiz-Merlo T; Corbella L; López-Medrano F; Polanco N; González E; San Juan R; Folgueira MD; Andrés A; Aguado JM
Am J Transplant; 2020 Aug; 20(8):2070-2080. PubMed ID: 31991045
[TBL] [Abstract][Full Text] [Related]
36. Single time point immune function assay (ImmuKnow) testing does not aid in the prediction of future opportunistic infections or acute rejection.
Huskey J; Gralla J; Wiseman AC
Clin J Am Soc Nephrol; 2011 Feb; 6(2):423-9. PubMed ID: 21088287
[TBL] [Abstract][Full Text] [Related]
37. Pre-transplant assessment of CMV-specific immune response by Elispot assay in kidney transplant recipients.
Rittà M; Costa C; Sidoti F; Ballocco C; Ranghino A; Messina M; Biancone L; Cavallo R
New Microbiol; 2015 Jul; 38(3):329-35. PubMed ID: 26147141
[TBL] [Abstract][Full Text] [Related]
38. Immunological monitoring of calcineurin inhibitors for predicting cytomegalovirus infection in kidney transplant recipients.
Couzi L; Thiébaut R; Carron JC; Moreau JF; Merville P; Taupin JL
Transplantation; 2008 Oct; 86(8):1060-7. PubMed ID: 18946343
[TBL] [Abstract][Full Text] [Related]
39. Cytomegalovirus infection: its incidence and management in cytomegalovirus-seropositive living related liver transplant recipients: a single-center experience.
Wadhawan M; Gupta S; Goyal N; Vasudevan KR; Makki K; Dawar R; Sardana R; Lal N; Kumar A
Liver Transpl; 2012 Dec; 18(12):1448-55. PubMed ID: 22903934
[TBL] [Abstract][Full Text] [Related]
40. Reassessing the impact of cytomegalovirus infection in kidney and kidney-pancreas transplantation.
Becker BN; Becker YT; Leverson GE; Simmons WD; Sollinger HW; Pirsch JD
Am J Kidney Dis; 2002 May; 39(5):1088-95. PubMed ID: 11979354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
